CME Group Inc. (CME)
NASDAQ
Market Cap
$85.57B
Sector
Financial Services
Industry
Financial—Data & Stock Exchanges
Rank in Sector
80 of 647
Rank in Industry
2 of 11
Largest Insider Buys in Sector
CME Stock Price History Chart
CME Stock Performance
About CME Group Inc.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Insider Activity of CME Group Inc.
Over the last 12 months, insiders at CME Group Inc. have bought $530,760 and sold $16.34M worth of CME Group Inc. stock.
On average, over the past 5 years, insiders at CME Group Inc. have bought $2.14M and sold $23.68M worth of stock each year.
Highest buying activity among insiders over the last 12 months: SHEPARD WILLIAM R (director) — $530,760.
The last purchase of 293 shares for transaction amount of $63,945 was made by SHEPARD WILLIAM R (director) on 2024‑09‑25.
List of Insider Buy and Sell Transactions, CME Group Inc.
| 2024-11-12 | Sale | director | 750 0.0002% | $226.33 | $169,751 | +3.84% | ||
| 2024-11-04 | Sale | director | 400 0.0001% | $222.92 | $89,168 | +2.67% | ||
| 2024-10-30 | Sale | Chief Information Officer | 4,500 0.0012% | $226.64 | $1.02M | +0.36% | ||
| 2024-10-30 | Sale | director | 1,000 0.0003% | $226.96 | $226,957 | +0.36% | ||
| 2024-10-28 | Sale | Sr MD Global Head Equity & FX | 1,374 0.0004% | $227.12 | $312,056 | -0.01% | ||
| 2024-09-25 | director | 292.65 <0.0001% | $218.50 | $63,945 | -0.01% | |||
| 2024-09-15 | Sale | Sr MD Chief Financial Officer | 754 0.0002% | $216.99 | $163,610 | -0.08% | ||
| 2024-08-30 | Sale | director | 7,593 0.0021% | $214.59 | $1.63M | +3.95% | ||
| 2024-06-25 | director | 325.88 <0.0001% | $195.07 | $63,569 | +13.31% | |||
| 2024-06-13 | Sale | director | 3,000 0.0008% | $195.44 | $586,320 | +11.67% | ||
| 2024-06-06 | Sale | director | 650 0.0002% | $201.44 | $130,937 | +8.06% | ||
| 2024-05-20 | Sale | director | 1,000 0.0003% | $211.52 | $211,520 | +1.98% | ||
| 2024-05-13 | Sale | director | 2,500 0.0007% | $210.65 | $526,620 | +2.27% | ||
| 2024-05-08 | Sale | Sr MD & Chief HR Officer | 7,140 0.002% | $210.35 | $1.5M | +0.94% | ||
| 2024-04-29 | Sale | Chairman and CEO | 40,000 0.0112% | $210.91 | $8.44M | +1.49% | ||
| 2024-03-26 | director | 294.5 <0.0001% | $214.71 | $63,231 | -0.19% | |||
| 2024-03-15 | Sale | Sr MD Global Head Equity & FX | 556 0.0002% | $217.50 | $120,930 | -2.23% | ||
| 2024-01-31 | Sale | Sr MD Global Head Equity & FX | 35 <0.0001% | $206.78 | $7,237 | +3.45% | ||
| 2024-01-18 | director | 1,389.88 0.0004% | $202.44 | $281,368 | +4.97% | |||
| 2023-12-28 | director | 278.22 <0.0001% | $210.79 | $58,646 | +0.46% |
Insider Historical Profitability
14.47%
| SHEPARD WILLIAM R | director | 255172 0.0708% | $237.45 | 26 | 6 | +19.29% |
| DUFFY TERRENCE A | Chairman and CEO | 67455 0.0187% | $237.45 | 3 | 25 | +4.34% |
| Durkin Bryan T | director | 55607 0.0154% | $237.45 | 0 | 19 | |
| Piell Hilda Harris | Sr MD & Chief HR Officer | 29256 0.0081% | $237.45 | 0 | 32 | |
| Cutinho Sunil | Chief Information Officer | 27053 0.0075% | $237.45 | 0 | 8 | |
| GEPSMAN MARTIN J | director | 25067 0.007% | $237.45 | 0 | 31 | |
| Cook Elizabeth A | director | 18239 0.0051% | $237.45 | 0 | 8 | |
| SAVAGE TERRY L | director | 17441 0.0048% | $237.45 | 1 | 1 | +19.22% |
| GLICKMAN DANIEL R | director | 14008 0.0039% | $237.45 | 0 | 7 | |
| Fitzpatrick Lynne | Sr MD Chief Financial Officer | 13261 0.0037% | $237.45 | 0 | 1 | |
| Bitsberger Timothy S. | director | 10589 0.0029% | $237.45 | 0 | 8 | |
| Carey Charles P | director | 7163 0.002% | $237.45 | 2 | 18 | +3.12% |
| McCourt Timothy Francis | Sr MD Global Head Equity & FX | 7275 0.002% | $237.45 | 0 | 5 | |
| MCNULTY JAMES J | President & CEO | 135214 0.0375% | $237.45 | 0 | 2 | |
| GILL PHUPINDER | CEO | 116222 0.0323% | $237.45 | 1 | 26 | +12.26% |
| TAYLOR KIMBERLY S | Former Sr MD&Pres.Clr&PostTrad | 112465 0.0312% | $237.45 | 0 | 41 | |
| SIEGEL HOWARD J | director | 74985 0.0208% | $237.45 | 0 | 10 | |
| Kometer Kevin | Sr MD Chief Information Office | 63207 0.0175% | $237.45 | 0 | 9 | |
| Parisi James E. | CFO & Sr MD Finance & Corp Dev | 47810 0.0133% | $237.45 | 1 | 11 | <0.0001% |
| Bernacchi Jeffrey M. | director | 42004 0.0117% | $237.45 | 0 | 6 | |
| Pietrowicz John W. | Sr MD Chief Financial Officer | 42330 0.0117% | $237.45 | 0 | 23 | |
| CRONIN KATHLEEN M | Sr MD Gen Counsel & Corp Secr | 40368 0.0112% | $237.45 | 0 | 31 | |
| OLIFF JAMES E | director | 35761 0.0099% | $237.45 | 1 | 21 | +15.64% |
| Holzrichter Julie | Sr MD Chief Operating Officer | 31990 0.0089% | $237.45 | 0 | 16 | |
| SANDNER JOHN F | director | 30000 0.0083% | $237.45 | 0 | 9 | |
| DONOHUE CRAIG S | CEO | 26734 0.0074% | $237.45 | 1 | 18 | +47.37% |
| Winkler Julie | Sr MD Chief Commercial Officer | 25373 0.007% | $237.45 | 0 | 9 | |
| Tully Sean | Sr MD Global Hd Financial & OT | 22032 0.0061% | $237.45 | 0 | 6 | |
| Donaldson James A | director | 20093 0.0056% | $237.45 | 0 | 6 | |
| Tobin Jack J | MD Chief Accounting Officer | 15754 0.0044% | $237.45 | 0 | 5 | |
| Vroman Ken | Sr MD International & Optimiza | 13063 0.0036% | $237.45 | 0 | 3 | |
| Zagotta Robert | Sr MD Strategy & Execution | 12375 0.0034% | $237.45 | 0 | 2 | |
| POLLOCK ALEX J | director | 11502 0.0032% | $237.45 | 2 | 0 | +33.72% |
| Tierney Robert J JR | director | 11609 0.0032% | $237.45 | 1 | 0 | +9.73% |
| Paulhac Laurent | Sr MD IR & OTC Prod & Svcs | 11175 0.0031% | $237.45 | 0 | 1 | |
| Pietrzak John L | director | 10702 0.003% | $237.45 | 0 | 3 | |
| MELAMED LEO | director | 10537 0.0029% | $237.45 | 0 | 8 | |
| SALATICH WILLIAM G JR | director | 10612 0.0029% | $237.45 | 0 | 3 | |
| Harley Jill A | MD & CAO | 10191 0.0028% | $237.45 | 0 | 12 | |
| GORDON SCOTT | director | 9000 0.0025% | $237.45 | 0 | 1 | |
| Rich Linda Dallas | Sr MD Govt Rel Legisl Affairs | 8039 0.0022% | $237.45 | 0 | 4 | |
| CLEGG JACKIE M | director | 7155 0.002% | $237.45 | 0 | 3 | |
| REDDING RICHARD H | MD Products & Services | 7165 0.002% | $237.45 | 0 | 11 | |
| Sprague Suzanne | Sr MD Global Head of Clearing | 6972 0.0019% | $237.45 | 0 | 1 | |
| Chadid Mazen | MD Operations | 5860 0.0016% | $237.45 | 0 | 8 | |
| Niciforo Joseph | director | 5137 0.0014% | $237.45 | 3 | 11 | <0.0001% |
| GERDES LARRY G | director | 4501 0.0012% | $237.45 | 3 | 0 | +2.83% |
| Cermak Mark E | director | 4270 0.0012% | $237.45 | 0 | 5 | |
| Pankau Ronald A. | director | 3906 0.0011% | $237.45 | 0 | 20 | |
| Suskind Dennis | director | 3167 0.0009% | $237.45 | 0 | 11 | |
| Pieper James V. | MD & CAO, other: MD & CAO | 3069 0.0009% | $237.45 | 0 | 2 | |
| KRAUSE JAMES R | MD & CIO | 2835 0.0008% | $237.45 | 0 | 10 | |
| GOMACH DAVID G | MD & CFO | 2490 0.0007% | $237.45 | 0 | 2 | |
| Corvino Robert F | director | 2501 0.0007% | $237.45 | 0 | 19 | |
| KEEVE EILEEN | MD Organizational Development | 1735 0.0005% | $237.45 | 0 | 19 | |
| LYNCH PATRICK B | director | 1888 0.0005% | $237.45 | 3 | 11 | +21.1% |
| Newsome James E | director | 1796 0.0005% | $237.45 | 0 | 2 | |
| NANDAPURKAR SATISH | Managing Director | 1300 0.0004% | $237.45 | 0 | 3 | |
| KATLER GARY M | director | 1000 0.0003% | $237.45 | 0 | 18 | |
| ROBERTS JOHN ROTH III | MD & CMO | 1000 0.0003% | $237.45 | 0 | 1 | |
| GOBLE NANCY W | MD & CAO | 813 0.0002% | $237.45 | 0 | 25 | |
| MILLER WILLIAM P II | director | 100 0% | $237.45 | 1 | 0 | +46.79% |
| WESCOTT DAVID J | director | 1 0% | $237.45 | 3 | 0 | +0.42% |
| Odom C C II | director | 3 0% | $237.45 | 0 | 32 | |
| Sammann Derek | Sr MD Gl Hd Commodity & Option | 0 0% | $237.45 | 0 | 16 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| The Vanguard Group | $7.19B | 9.28 | 33.4M | -0.14% | -$10.3M | 0.13 | |
| BlackRock | $5.49B | 7.08 | 25.49M | +6.26% | +$323.4M | 0.12 | |
| Capital International Investors | $3.4B | 4.39 | 15.81M | +24.1% | +$660.9M | 0.69 | |
| State Street | $3.38B | 4.36 | 15.71M | -1.22% | -$41.93M | 0.14 | |
| JPMorgan Chase | $3.24B | 4.18 | 15.06M | +3.21% | +$100.77M | 0.29 | |
| Capital World Investors | $2.84B | 3.66 | 13.18M | -9.63% | -$302.56M | 0.47 | |
| Geode Capital Management | $1.71B | 2.21 | 7.94M | +5.4% | +$87.44M | 0.15 | |
| BNY Mellon | $1.46B | 1.89 | 6.79M | +2.88% | +$40.87M | 0.27 | |
| Morgan Stanley | $1.18B | 1.53 | 5.5M | +0.84% | +$9.85M | 0.09 | |
| Parnassus Investments Ca | $1.17B | 1.51 | 5.45M | -3.91% | -$47.73M | 2.51 | |
| Ameriprise Financial | $1.02B | 1.32 | 4.75M | +13.87% | +$124.44M | 0.28 | |
| Fil Ltd | $898.44M | 1.16 | 4.17M | -2.25% | -$20.7M | 0.88 | |
| GuardCap Asset Management Limited | $863.11M | 1.11 | 4.01M | +1.09% | +$9.32M | 10.58 | |
| Invesco | $834.01M | 1.08 | 3.87M | +24.73% | +$165.37M | 0.17 | |
| Northern Trust | $794.32M | 1.03 | 3.69M | -2.37% | -$19.32M | 0.13 | |
| Capital Research Global Investors | $783.71M | 1.01 | 3.64M | -44.77% | -$635.33M | 0.18 | |
| Fiera Capital | $770.41M | 0.99 | 3.58M | +3.18% | +$23.72M | 2.25 | |
| Vontobel Asset Management Inc | $787.78M | 0.96 | 3.44M | -5.89% | -$49.31M | 4.37 | |
| Fidelity Investments | $660.58M | 0.85 | 3.07M | -38.19% | -$408.22M | 0.04 | |
| T. Rowe Price | $634.02M | 0.82 | 2.94M | -18.54% | -$144.31M | 0.08 | |
| Raymond James Associates | $631.84M | 0.82 | 2.93M | +4.98% | +$29.95M | 0.43 | |
| Massachusetts Financial Services Co Ma | $629.19M | 0.81 | 2.92M | +14.49% | +$79.62M | 0.19 | |
| Bank of America | $575.99M | 0.74 | 2.68M | +30.78% | +$135.56M | 0.06 | |
| Legal & General | $572.49M | 0.74 | 2.66M | -0.3% | -$1.73M | 0.13 | |
| Goldman Sachs | $559.63M | 0.72 | 2.6M | +10.61% | +$53.68M | 0.1 | |
| Neuberger Berman | $522.66M | 0.67 | 2.43M | -29.37% | -$217.36M | 0.43 | |
| Amundi | $496.24M | 0.66 | 2.36M | +3.26% | +$15.66M | 0.21 | |
| Sarasin & Partners LLP | $491.78M | 0.63 | 2.28M | +1.34% | +$6.53M | 4.84 | |
| Janus Henderson | $466.59M | 0.6 | 2.17M | -26.98% | -$172.42M | 0.23 | |
| CalPERS | $452.76M | 0.58 | 2.1M | -16.93% | -$92.29M | 0.32 | |
| Ubs Asset Management Americas Inc | $427.95M | 0.55 | 1.99M | -0.29% | -$1.23M | 0.15 | |
| Charles Schwab | $413.65M | 0.53 | 1.92M | +1.39% | +$5.66M | 0.09 | |
| Cibc Private Wealth Group Llc | $390.35M | 0.51 | 1.84M | -1.69% | -$6.71M | 0.76 | |
| Arrowstreet Capital, Limited Partnership | $388.94M | 0.5 | 1.81M | +48.07% | +$126.26M | 0.36 | |
| Cantillon Capital Management LLC | $388.08M | 0.5 | 1.8M | -1.96% | -$7.77M | 2.44 | |
| PRIMECAP Management Co | $387.74M | 0.5 | 1.8M | +0.74% | +$2.86M | 0.29 | |
| Royal Bank of Canada | $361.89M | 0.47 | 1.68M | -8.82% | -$35.02M | 0.09 | |
| Barclays | $360.32M | 0.47 | 1.67M | +40.56% | +$103.97M | 0.16 | |
| UBS | $354.69M | 0.46 | 1.65M | +0.18% | +$643,932.39 | 0.11 | |
| Capital Wealth Planning, LLC | $321.38M | 0.42 | 1.49M | +23.98% | +$62.17M | 3.44 | |
| APG Asset Management | $257.82M | 0.36 | 1.29M | +0.54% | +$1.38M | 0.45 | |
| AustralianSuper | $269.62M | 0.35 | 1.27M | +28.4% | +$59.63M | 1.58 | |
| Rathbone Brothers | $272.38M | 0.35 | 1.27M | +20.67% | +$46.66M | 1.54 | |
| Thornburg Investment Management | $270.79M | 0.35 | 1.26M | -21.86% | -$75.74M | 3.79 | |
| Deutsche Bank | $266.09M | 0.34 | 1.24M | +6.19% | +$15.51M | 0.12 | |
| Harding Loevner LP | $249.51M | 0.32 | 1.16M | -7.63% | -$20.62M | 1.54 | |
| Nuveen | $245.63M | 0.32 | 1.14M | -2.77% | -$6.98M | 0.07 | |
| Fayez Sarofim &a; Co. | $245.23M | 0.32 | 1.14M | +2.85% | +$6.8M | 0.73 | |
| Wells Fargo | $240.55M | 0.31 | 1.12M | +1.65% | +$3.91M | 0.06 | |
| AQR Capital | $239.47M | 0.31 | 1.11M | +28.63% | +$53.3M | 0.37 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.